RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 53 filers reported holding RECRO PHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $765,141 | -57.9% | 1,631,431 | -1.2% | 0.00% | -60.0% |
| Q2 2023 | $1,816,869 | -7.1% | 1,651,699 | +0.5% | 0.01% | 0.0% |
| Q1 2023 | $1,956,715 | -1.2% | 1,644,298 | +23.7% | 0.01% | 0.0% |
| Q4 2022 | $1,979,900 | +19.2% | 1,328,792 | +30.4% | 0.01% | 0.0% |
| Q3 2022 | $1,661,000 | +139.0% | 1,019,078 | +16.5% | 0.01% | +150.0% |
| Q2 2022 | $695,000 | -56.8% | 874,653 | -2.0% | 0.00% | -50.0% |
| Q1 2022 | $1,607,000 | +82.2% | 892,683 | +73.1% | 0.00% | +100.0% |
| Q4 2021 | $882,000 | +191.1% | 515,596 | +250.1% | 0.00% | +100.0% |
| Q3 2021 | $303,000 | +818.2% | 147,260 | +929.8% | 0.00% | – |
| Q2 2021 | $33,000 | – | 14,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MAK CAPITAL ONE LLC | 850,129 | $2,423,000 | 0.65% |
| Newtyn Management, LLC | 700,000 | $1,995,000 | 0.46% |
| Portolan Capital Management | 1,293,376 | $3,686,000 | 0.34% |
| Rubric Capital Management LP | 1,076,587 | $3,068,000 | 0.22% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 99,046 | $282,000 | 0.04% |
| Alyeska Investment Group, L.P. | 736,821 | $2,100,000 | 0.03% |
| STEPHENS INC /AR/ | 510,569 | $1,455,000 | 0.03% |
| Clear Harbor Asset Management, LLC | 46,682 | $133,000 | 0.02% |
| WYNNEFIELD CAPITAL INC | 13,000 | $37,000 | 0.02% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 451,301 | $1,286,000 | 0.01% |